July 14, 2022
Enabling next generation cardiac therapeutics with genetic engineering and novel in vivo models for cardiomyocyte transplantation – Year two
The development of cellular therapeutics is acutely dependent on the ability to evaluate the functional characteristics of the cells in predictive animal models. This forms the basis of key pre-clinical data packages that are key for regulatory submissions preceding human clinical trials. The development of appropriate model systems, the execution of the surgical techniques to […]
Read More